Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-21 Sale | 2025-02-27 8:54 pm | Singular Genomics Systems Inc. | OMIC | TANG KEVIN TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 372,000 | $0 | $0 | 0 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-18 4:31 pm | Singular Genomics Systems Inc. | OMIC | TANG KEVIN TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 122,416 | $14.75 | $1,806,220 | 372,000 (Indirect) | View |
| 2023-12-14 Sale | 2023-12-18 6:29 pm | Rain Oncology Inc. | RAIN | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 173,973 | $1.2037 | $209,413 | 3,850,513 (Indirect) | View |
| 2023-10-11 Purchase | 2023-10-13 4:57 pm | Rain Oncology Inc. | RAIN | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 284,145 | $0.982 | $279,030 | 4,024,486 (Indirect) | View |
| 2023-05-30 Purchase | 2023-06-01 6:46 pm | Rain Oncology Inc. | RAIN | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 1,088,273 | $1.0648 | $1,158,764 | 3,740,341 (Indirect) | View |
| 2023-05-25 Purchase | 2023-05-30 8:02 pm | TCR2 THERAPEUTICS INC. | TCRR | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 50,000 | $1.72 | $86,000 | 4,394,800 (Indirect) | View |
| 2023-05-11 Purchase | 2023-05-15 5:12 pm | TCR2 THERAPEUTICS INC. | TCRR | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 44,948 | $1.95 | $87,649 | 4,344,800 (Indirect) | View |
| 2023-05-08 Purchase | 2023-05-10 7:02 pm | TCR2 THERAPEUTICS INC. | TCRR | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 83,988 | $1.95 | $163,777 | 4,299,852 (Indirect) | View |
| 2023-05-03 Purchase | 2023-05-05 6:52 pm | TCR2 THERAPEUTICS INC. | TCRR | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 289,577 | $1.8922 | $547,944 | 4,215,864 (Indirect) | View |
| 2023-03-13 Purchase | 2023-03-14 8:39 pm | Jounce Therapeutics Inc. | JNCE | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 85,987 | $0.99966 | $85,958 | 5,300,087 (Indirect) | View |
| 2021-11-29 Sale | 2021-12-01 7:07 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 441,290 | $3.9297 | $1,734,150 | 9,607,934 (Indirect) | View |
| 2021-11-23 Sale | 2021-11-26 1:02 pm | Aptevo Therapeutics Inc. | APVO | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP Exit Filing | 921,336 | $11.25 | $10,368,236 | 0 (Indirect) | View |
| 2021-11-18 Sale | 2021-11-22 5:26 pm | Aptevo Therapeutics Inc. | APVO | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 838,664 | $7.7509 | $6,500,411 | 921,336 (Indirect) | View |
| 2021-11-17 Sale | 2021-11-19 4:38 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Chief Executive Officer 10% Owner | 2,747,131 | $2.086 | $5,730,557 | 12,767,435 (Indirect) | View |
| 2021-05-27 Purchase | 2021-06-01 6:42 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 245,020 | $4.4719 | $1,095,693 | 10,049,224 (Indirect) | View |
| 2021-05-24 Purchase | 2021-05-26 4:56 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 398,714 | $3.9571 | $1,577,731 | 9,804,204 (Indirect) | View |
| 2020-12-21 Purchase | 2020-12-23 4:41 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Chief Executive Officer 10% Owner | 275,784 | $15.16 | $4,181,208 | 15,514,566 (Indirect) | View |
| 2020-11-04 Purchase | 2020-11-06 4:47 pm | Aptevo Therapeutics Inc. | APVO | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 1,436,675 | $17.3 | $24,849,231 | 1,760,000 (Indirect) | View |
| 2020-09-28 Purchase | 2020-09-30 4:01 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S Chief Executive Officer 10% Owner | 110,882 | $13.13 | $1,456,408 | 15,238,782 (Indirect) | View |
| 2020-09-04 Purchase | 2020-09-09 6:55 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 278,369 | $3.9402 | $1,096,829 | 9,405,490 (Indirect) | View |
| 2020-08-28 Purchase | 2020-09-01 08:17 am | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S Chief Executive Officer 10% Owner | 1,052,631 | $14.25 | $14,999,992 | 15,127,900 (Indirect) | View |
| 2020-08-12 Purchase | 2020-08-14 4:49 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 431,647 | $3.7185 | $1,605,100 | 9,127,121 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-09-18 4:27 pm | N/A N/A | Singular Genomics Systems Inc. | OMIC | TANG KEVIN TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 0 | $0 | 249,584 (Indirect) | View |
| 2023-06-01 Other | 2024-02-14 5:25 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 4,394,800 | $0 | 4,394,800 (Indirect) | View |
| 2024-01-26 Equity Swap | 2024-02-02 4:00 pm | N/A N/A | Rain Oncology Inc. | RAIN | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 3,850,513 | $0 | 0 (Indirect) | View |
Ownership | 2023-06-01 6:44 pm | N/A N/A | Rain Oncology Inc. | RAIN | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 0 | $0 | 2,652,068 (Indirect) | View |
Ownership | 2023-05-05 6:49 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 0 | $0 | 3,926,287 (Indirect) | View |
| 2023-05-03 Equity Swap | 2023-05-05 4:37 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP Director 10% Owner | 5,300,087 | $1.85 | 20,000 (Indirect) | View |
| 2023-05-03 Other | 2023-05-05 4:37 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP Director 10% Owner | 10,000 | $9,738 | 20,000 (Indirect) | View |
Ownership | 2023-03-14 8:38 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 0 | $0 | 5,214,100 (Indirect) | View |
| 2022-08-22 Equity Swap | 2022-08-24 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 9,607,934 | $6.23 | 0 (Indirect) | View |
| 2022-08-22 Equity Swap | 2022-08-24 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 3,519 | $0 | 0 (Indirect) | View |
Ownership | 2020-11-06 4:47 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 0 | $0 | 323,325 (Indirect) | View |